Compound or practice · Supplement

Fisetin

A flavonoid senolytic star in mice with essentially no completed human outcome data — trials are ongoing.

Overall grade
Grade D
Last revised
1
graded outcome
0
references listed

A structured monograph in Prometheus's bundled library. Its grades are the monograph's own reading of the evidence, not a peer-reviewed review.

1 at grade D — 1 graded row

What is known

Each outcome with its grade (how strong the evidence is, A to D), the size of the effect where the entry records one, and how often studies agree.

  • Senolytic / healthspan (humans)Evidence grade D

    No completed human outcomes

    Unclearlow

What is uncertain

Read off the same rows as above. Nothing here is added that the entry does not itself record.

  • Thin evidence: Senolytic / healthspan (humans) (grade D).

The evidence in words

What it is

Fisetin is a flavonoid (strawberries) that emerged as a leading senolytic candidate in animal studies.

How it works

It appears to clear senescent 'zombie' cells that accumulate with age and drive inflammation.

What the evidence shows

The mouse data are striking; human clinical-outcome data are essentially absent, with trials underway. Enthusiasm is running well ahead of evidence. Safe as a food flavonoid.

How to use it

Experimental; some protocols use intermittent high doses — not established.

Safety & interactions

Food flavonoid, appears safe; human dosing unestablished.

Bottom line

Exciting in mice, unproven in humans. Wait for the trials before betting on it.

How it is used

As the entry records it, from the studies it summarises. Not a recommendation for you — doses that suit a trial population may not suit you.

Experimental
Not established.

Entries that share this one's tags or conditions.

Sources

This entry lists no references of its own.

Last revised . A grade is this entry's reading of the evidence, not medical advice.